AstraZeneca prices USD2 billion multi-year bond issuance
(Alliance News) - AstraZeneca PLC on Thursday priced a global bond offering worth USD2 billion. Read More
| Price | 15,110.00p on 26-02-2026 at 17:30:00 |
|---|---|
| Change | -108.00p -0.71% |
| Buy | 15,116.00p |
| Sell | 15,112.00p |
| Last Trade: | Unknown 0.00 at 15,069.38824p |
| Day's Volume: | 2,004,601 |
| Last Close: | 15,110.00p |
| Open: | 15,144.00p |
| ISIN: | GB0009895292 |
| Day's Range | 15,002.00p - 15,358.00p |
| 52wk Range: | 9,574.00p - 15,730.00p |
| Market Capitalisation: | £234.32b |
| VWAP: | 15,142.33194p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 0 | 15,069.38824p | SI Trade Currency Conversion |
17:23:12 - 26-Feb-26 |
| Unknown* | 0 | 15,073.0781p | SI Trade Currency Conversion |
17:13:58 - 26-Feb-26 |
| Unknown* | 1 | 15,084.88565p | SI Trade Currency Conversion |
17:05:33 - 26-Feb-26 |
| Unknown* | 0 | 15,084.88565p | SI Trade Currency Conversion |
17:04:47 - 26-Feb-26 |
| Unknown* | 0 | 15,084.88565p | Currency Conversion OTC Trade |
17:04:02 - 26-Feb-26 |
| Unknown* | 0 | 15,070.86418p | SI Trade Currency Conversion |
16:49:01 - 26-Feb-26 |
| Sell* | 10,360 | 15,110.00p | SI Trade Suspected SELL Trade |
16:48:42 - 26-Feb-26 |
| Unknown* | 1 | 15,045.03516p | SI Trade Currency Conversion |
16:48:05 - 26-Feb-26 |
| Buy* | 149 | 15,178.999p | SI Trade Negotiated Trade |
16:47:06 - 26-Feb-26 |
| Unknown* | 0 | 15,056.10474p | SI Trade Currency Conversion |
16:46:05 - 26-Feb-26 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 25th Feb 2026 7:00 am | RNS | Filing of Form 20-F with SEC |
| 24th Feb 2026 11:00 am | RNS | Annual Financial Report |
| 24th Feb 2026 7:00 am | RNS | Directorate change |
| 20th Feb 2026 7:00 am | RNS | Fixed-duration Calquence combo approved in US |
| 10th Feb 2026 7:00 am | RNS | Final Results |
| 3rd Feb 2026 7:00 am | RNS | Update on Saphnelo subcutaneous administration |
| 2nd Feb 2026 3:00 pm | RNS | Total Voting Rights |
| 2nd Feb 2026 7:05 am | RNS | Imfinzi recommended in EU for early gastric cancer |
| 2nd Feb 2026 7:00 am | RNS | AstraZeneca begins trading on NYSE |
| 30th Jan 2026 7:00 am | RNS | AstraZeneca agrees obesity and T2D deal with CSPC |